Navigation Links
LifeSync Hires Dr. Mark Phelps to Lead Research & Development
Date:2/20/2008

FORT LAUDERDALE, Fla., Feb. 20 /PRNewswire/ -- LifeSync Corporation is pleased to announce the appointment of Mark Phelps, Ph.D., as Senior Vice President of Research and Development. Dr. Phelps, who will report to President and CEO Shelley Hartman, will be responsible for leading all product design and development at LifeSync, including building the Company's Technology Center at the Georgia Electronic Design Center (GEDC) at the Georgia Institute of Technology in Atlanta.

Dr. Phelps comes to LifeSync with over eighteen years experience in the design and development of high technology and wireless products for the medical, automotive and defense industries. Dr. Phelps joined LifeSync from Medtronic, Inc. where he recently led the Electronic Systems Technology as well as new Therapies and Diagnostics Product Development at the Microelectronics Center in Tempe, Arizona. Prior to Medtronic, he held leadership positions at Motorola's Sensor Products Division in Tempe, Arizona, and Texas Instrument's Defense Systems and Electronics Group in Dallas, Texas. Dr. Phelps received B.S. (Summa Cum Laude), M.S. and Ph.D. degrees in electrical engineering and holds a certification in Materials and Science Engineering from the Florida Institute of Technology, Melbourne, FL.

"I am very excited to have a senior executive of such high caliber join the LifeSync team," said Shelley Hartman, Chief Executive Officer and President of LifeSync. "Dr. Phelps' extensive background in the development of innovative, wireless medical products will accelerate the company's delivery of next generation wireless systems."

LifeSync Corporation is a medical device company dedicated to the continued development, marketing and sale of The LifeSync(R) Wireless ECG System. The LifeSync(R) System is the first wireless electrocardiogram (ECG) data communication system appropriate for use in hospital and outpatient settings where cardiac ECG and respiration monitoring are require
'/>"/>

SOURCE LifeSync Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. LifeSync Corporation Appoints Nancy McLane as Senior Vice President Operations
2. Pioneer Surgical Technology Hires Vice President of New Business Development
3. WeissComm Partners Makes 10 New Hires as It Wins New Accounts and Grows Existing Business
4. LehmanMillet Continues Expansion with Strategic Hires
5. AXA Equitable Life Insurance Co. Hires William McDermott to Lead Corporate Retirement Planning Business
6. Staffing Agency Hires Local Television News Team, Launches Broadband Network for Nurses
7. Medi-Promotions Hires Industry Executive to Expand its Medi-Scripts Prescription Pad Model
8. Pioneer Surgical Technology Hires New Spinal Franchise Manager
9. ReBuilder Medical Technologies, Inc. Hires Nurses Exclusively to Provide Customer Support
10. FBR Capital Markets Hires Senior Healthcare Analyst
11. Casey Family Programs Hires Ken Patterson as Managing Director of Child and Family Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...HINGTON, July 25 /PRNewswire/ -- Klafter & Olsen L...Care Corporation ("ArthroCare" or the,"Company") (... U.S. District,Court for the Western District of T...hased the common stock ArthroCare from January 24,...chaser Class Period") and all,persons or entities ...
(Date:7/25/2008)...ASANTON, Calif., July 25 /PRNewswire-FirstCall/ --...der in device-based mechanical,circulatory support...arts,today announced that it will report its oper... months of fiscal 2008 on Thursday, July 31., The...s financial,results and operating activities to al...
(Date:7/25/2008)...ROOK, Ill. July 25, 2008 The American Society f...idelines on the role of endoscopy in the bariatric... in the United States and the success in surgical ...er of weight-loss surgeries performed in the U.S.,...lines discuss endoscopy in the preoperative patien...
(Date:7/25/2008)...ivanCotter Releases Results of Fourth Annual Physi...urvey, DETROIT, July 25 /PRNewswire/ -- Sullivan,...rth annual survey of physician on-call pay rates a...y Report. The survey report,with data from 132 he...ian,on-call pay practices and rates paid for 33 ph...
Breaking Medicine News(10 mins):Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 2Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 3Health News:Thoratec Schedules Second Quarter 2008 Conference Call, Webcast 2Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 2Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 3Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 2Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 3
...nal of Sexual Medicine examines differences in sex...m, in pre- and post-menopausal women . Participant...ed concerns regarding their own feelings of sexual...els of desire to be normal. An assessment tool wa...
...ty in the UK have discovered mutations in the DNA ...n triggering breast cancer in women . The discove...ger women at higher-than-average risk of breast ca...with mammography before they reach 50 - the age wh...
...ey see, monkey do.' Researchers at Ohio Universit...ty to see red, they began to develop red and orang...eys, such as macaques and leaf monkeys, all have t...se primates to distinguish between blue, green and...
...y quit are more likely to try kicking the habit an...t the University of Rochester . Rochester researc...edicine at the University of Rochester School of M...ew findings at a Toronto conference this month tha...
Other Medicine News:Health News:Pre- and Post-menopausal Women Responses Equally to Most Sexual Desire Cues 2Health News:UK Scientists Identify Gene Mutations That Trigger Breast Cancer 2Health News:UK Scientists Identify Gene Mutations That Trigger Breast Cancer 3Health News:Color Vision Drove Primates to Develop Red Skin and Hair, Study Finds 2Health News:Choice is a Key Element in Success for Smokers Who Want to Quit 2
(Date:7/23/2008)...y 23 /PRNewswire-USNewswire/ -- The following was,...rman Conyers, Ranking Member Smith, and Members of...estify today., Since I appeared before this Commi...ter acquainted with the talented and dedicated pro...work they do, and I have come to,appreciate that m...
(Date:7/23/2008)...3 /- Dendreon Corporation,(...e Independent Data,Monitoring Committee (IDMC) to ...rall survival relating to the Company,s Phase 3 IM...eatment, also known as D9902B) clinical trial,of P...,s investigational,active cellular immunotherapy f...
(Date:7/22/2008)...ly 22 /- Nonin Medical, a leading inn...ore than 20 years, has entered,the clinical testin...e,regional oxygen saturation. Today,s most common ...monitoring of the regional blood oxygenation,in th... and outcomes from an ongoing clinical study at th...
(Date:7/22/2008)... PET Study Confirms Tyrima Exhibits Excellent Drug... - Results Support Initiation of Phase II Clini...22 /- CeNeRx BioPharma,Inc., a clini...nnovative,treatments for diseases of the central n...s lead candidate Tyrima(TM) into Phase II trials f...
Breaking Medicine Technology:Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 2Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 4Study examines cold medication use in young children 20744 1Study examines cold medication use in young children 20744 2Living fossils have long and short term memory 3492 1Mutual Protection Trust Earns Third A+ Rating From A M Best 20741 1Mutual Protection Trust Earns Third A+ Rating From A M Best 20741 2U S News Ranks Cincinnati Childrens Among Top Three U S Childrens Hospitals 20738 1U S News Ranks Cincinnati Childrens Among Top Three U S Childrens Hospitals 20738 2U S News Ranks Cincinnati Childrens Among Top Three U S Childrens Hospitals 20738 3
...07—The drug levosimendan did not improve,sur...e when,compared with a more widely-used treatment ...dy in the May 2 issue of, JAMA . , Acute decompens...racterized by inability of the heart to maintain a...of hospitalization worldwide,but appropriate trea...
... Confirms and Extends Evidence Seen in a,Previous ...FirstCall/ --,BioCryst Pharmaceuticals, Inc. today...,s Research Hospital, Memphis, TN, reported,favora...nimal model,of influenza using a highly virulent s...t had caused fatal human infection in Viet,Nam). T...
Other Medicine Technology:Drug for Treatment of Heart Failure Does Not Improve Survival,Compared to More Widely-used Medication 2St. Jude Study Shows Effectiveness of Peramivir in Prevention of,Mortality in Mouse Model of Avian Influenza H5N1 Virus Infection 2St. Jude Study Shows Effectiveness of Peramivir in Prevention of,Mortality in Mouse Model of Avian Influenza H5N1 Virus Infection 3St. Jude Study Shows Effectiveness of Peramivir in Prevention of,Mortality in Mouse Model of Avian Influenza H5N1 Virus Infection 4St. Jude Study Shows Effectiveness of Peramivir in Prevention of,Mortality in Mouse Model of Avian Influenza H5N1 Virus Infection 5St. Jude Study Shows Effectiveness of Peramivir in Prevention of,Mortality in Mouse Model of Avian Influenza H5N1 Virus Infection 6
These objectives have more contrast than the DLL objectives for enhanced contrast with tissue culture specimens. These objectives are designed for use on inverted microscopes and therefore their mark
...microscope technology that offers you much more th...s category. You will be impressed by the outstandi...n designed to make lab work as easy and safe as po...kflow. Your advantage: more time for the observati...
... advanced inverted microscope for automated live c...tion CFI60 optics, and extendible infinity design ...on, its super-nanoprecision z-axis motorized focus...for precise imaging in 3D. It's the first inverte...
... an innovative and efficient inverted routine micr...earch facility. , ,Outstanding Optical Performanc...ll magnifications. Objectives deliver superb optic...chromatic aberration free correction (CF), and top...
Medicine Products: